A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors

Jayesh Desai, Ben Markman, Shahneen Kaur Sandhu, Hui Kong Gan, Michael Friedlander, Ben Tran, Tarek Meniawy, Vishal Boolell, Duncan Colyer, Christie Norris, Malaka Ameratunga, Jason Yang, Kang Li, Lai Wang, Lusong Luo, Zhen Qin, Michael Millward

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Volume34
Issue number15
DOIs
Publication statusPublished - 20 May 2016
EventAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States
Duration: 3 Jun 20167 Jun 2016

Cite this

Desai, Jayesh ; Markman, Ben ; Sandhu, Shahneen Kaur ; Gan, Hui Kong ; Friedlander, Michael ; Tran, Ben ; Meniawy, Tarek ; Boolell, Vishal ; Colyer, Duncan ; Norris, Christie ; Ameratunga, Malaka ; Yang, Jason ; Li, Kang ; Wang, Lai ; Luo, Lusong ; Qin, Zhen ; Millward, Michael. / A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors. In: Journal of Clinical Oncology. 2016 ; Vol. 34, No. 15.
@article{476660b8a6384abb81f6889823c9aad8,
title = "A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors",
author = "Jayesh Desai and Ben Markman and Sandhu, {Shahneen Kaur} and Gan, {Hui Kong} and Michael Friedlander and Ben Tran and Tarek Meniawy and Vishal Boolell and Duncan Colyer and Christie Norris and Malaka Ameratunga and Jason Yang and Kang Li and Lai Wang and Lusong Luo and Zhen Qin and Michael Millward",
year = "2016",
month = "5",
day = "20",
doi = "10.1200/JCO.2016.34.15_suppl.3066",
language = "English",
volume = "34",
journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "15",

}

Desai, J, Markman, B, Sandhu, SK, Gan, HK, Friedlander, M, Tran, B, Meniawy, T, Boolell, V, Colyer, D, Norris, C, Ameratunga, M, Yang, J, Li, K, Wang, L, Luo, L, Qin, Z & Millward, M 2016, 'A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors' Journal of Clinical Oncology, vol. 34, no. 15. https://doi.org/10.1200/JCO.2016.34.15_suppl.3066

A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors. / Desai, Jayesh; Markman, Ben; Sandhu, Shahneen Kaur; Gan, Hui Kong; Friedlander, Michael; Tran, Ben; Meniawy, Tarek; Boolell, Vishal; Colyer, Duncan; Norris, Christie; Ameratunga, Malaka; Yang, Jason; Li, Kang; Wang, Lai; Luo, Lusong; Qin, Zhen; Millward, Michael.

In: Journal of Clinical Oncology, Vol. 34, No. 15, 20.05.2016.

Research output: Contribution to journalAbstract/Meeting Abstract

TY - JOUR

T1 - A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors

AU - Desai, Jayesh

AU - Markman, Ben

AU - Sandhu, Shahneen Kaur

AU - Gan, Hui Kong

AU - Friedlander, Michael

AU - Tran, Ben

AU - Meniawy, Tarek

AU - Boolell, Vishal

AU - Colyer, Duncan

AU - Norris, Christie

AU - Ameratunga, Malaka

AU - Yang, Jason

AU - Li, Kang

AU - Wang, Lai

AU - Luo, Lusong

AU - Qin, Zhen

AU - Millward, Michael

PY - 2016/5/20

Y1 - 2016/5/20

U2 - 10.1200/JCO.2016.34.15_suppl.3066

DO - 10.1200/JCO.2016.34.15_suppl.3066

M3 - Abstract/Meeting Abstract

VL - 34

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

SN - 0732-183X

IS - 15

ER -